Primary endometrial natural killer (NK)/T cell lymphoma: case report and review of literature

Primary natural killer (NK)/T cell lymphoma of the uterus is extremely rare. A case of primary NK/T cell lymphoma arising from the endometrium of the uterus was diagnosed by curettage which demonstrated the typical pathological characteristics of NK/T cell lymphoma. The patient received induction chemotherapy but refused hysterectomy. Later she developed bone marrow infiltration and eventually died on day 76 after diagnosis. The natural course of primary endometrial (NK)/T cell lymphoma was very aggressive. Conventional cytotoxic chemotherapy may be ineffective for this aggressive disease.

Endometrium; NK/T cell lymphoma; Extranasal type

[1] Latteri M.A., Cipolla C., Gebbia V., Lampasona G., Amato C., Gebbia N.: “Primary extranodal non-hodgkin lymphomas of the uterus and the breast: Report of three cases”. Eur. J. Surg. Oncol., 1995, 21, 432.

[2] Briese J., Noack F., Harland A., Horny H.P.: “Primary extranodal nk/t cell lymphoma (“Nasal type”) of the endometrium: Report of an unusual case diagnosed at autopsy”. Gynecol. Obstet. Invest., 2006, 61, 164.

[3] Chim C.S., Choy C., Liang R., Kwong Y.L.: “Isolated uterine relapse of nasal t/nk cell lymphoma”. Leuk Lymphoma, 1999, 34, 629.

[4] Mhawech P., Medeiros L.J., Bueso-Ramos C., Coffey D.M., Gei A.F., Shahab I.: “Natural killer-cell lymphoma involving the gynecologic tract”. Arch. Pathol. Lab. Med., 2000, 124, 1510.

[5] Murase T., Inagaki H., Takagi N., Okabe M., Eimoto T.: “Nasal nkcell lymphoma followed by relapse in the uterine cervix”. Leuk Lymphoma, 2002, 43, 203.

[6] Nakamura S., Kato M., Ichimura K., Yatabe Y., Kagami Y., Suzuki R. et al.: “Peripheral t/natural killer-cell lymphoma involving the female genital tract: A clinicopathologic study of 5 cases”. Int. J. Hematol., 2001, 73, 108.

[7] Lagoo A.S., Robboy S.J.: “Lymphoma of the female genital tract: Current status”. Int. J. Gynecol. Pathol., 2006, 25, 1.

[8] Freeman C., Berg J.W., Cutler S.J.: “Occurrence and prognosis of extranodal lymphomas”. Cancer, 1972, 29, 252.

[9] Chorlton I., Norris H.J., King F.M.: “Malignant reticuloendothelial disease involving the ovary as a primary manifestation: A series of 19 lymphomas and 1 granulocytic sarcoma”. Cancer, 1974, 34, 397.

[10] van de Rijn M., Kamel O.W., Chang P.P., Lee A., Warnke R.A., Salhany K.E.: “Primary low-grade endometrial b-cell lymphoma”. Am. J. Surg. Pathol., 1997, 21, 187.

[11] Harris N.L., Scully R.E.: “Malignant lymphoma and granulocytic sarcoma of the uterus and vagina. A clinicopathologic analysis of 27 cases”. Cancer, 1984, 53, 2530.

[12] Cahill L.A., Stastny J.F., Frable W.J.: “Primary lymphoma of the endometrium. A report of two cases diagnosed on cervicovaginal smears”. Acta Cytol., 1997, 41, 533.

[13] Renno S.I., Moreland W.S., Pettenati M.J., Beaty M.W., Keung Y.K.: “Primary malignant lymphoma of uterine corpus: Case report and review of the literature”. Ann. Hematol., 2002, 81, 44.

[14] Hachisuga T., Ookuma Y., Fukuda K., Iwasaka T., Sugimori H., Watanabe T.: “Detection of epstein-barr virus DNA from a lymphoma-like lesion of the uterine cervix”. Gynecol. Oncol., 1992, 46, 69.

[15] Kim J.E., Kim Y.A., Jeon Y.K., Park S.S., Heo D.S., Kim C.W.: “Comparative analysis of nk/t-cell lymphoma and peripheral t-cell lymphoma in korea: Clinicopathological correlations and analysis of ebv strain type and 30-bp deletion variant lmp1”. Pathol. Int., 2003, 53, 735.

[16] Martin C., Carrasco C., Sotomayor C., Otth C.: “Prevalence of epstein-barr virus associated with nasal lymphoma in patients attending the regional hospital of valdivia, chile, between 1987 and 2005”. J. Med. Virol., 2010, 82, 825.

[17] Wang Z.Y., Li Y.X., Wang W.H., Jin J., Wang H., Song Y.W. et al.: “Primary radiotherapy showed favorable outcome in treating extranodal nasal-type nk/t-cell lymphoma in children and adolescents”. Blood, 2009, 114, 4771.

[18] Drenou B., Amiot L., Lamy T., Le Prise P.Y., Fauchet R.: “Multidrug resistance in aggressive lymphoproliferative disorders of t and natural-killer origin”. Leuk Lymphoma, 1998, 30, 381.

[19] Ando M., Sugimoto K., Kitoh T., Sasaki M., Mukai K., Ando J., Egashira M., Schuster S.M., Oshimi K.: “Selective apoptosis of natural killer-cell tumours by l-asparaginase”. Br. J. Haematol., 2005, 130, 860.

[20] Jaccard A,. Petit B., Girault S., Suarez F., Gressin R., Zini J.M. et al.: “L-asparaginase-based treatment of 15 western patients with extranodal nk/t-cell lymphoma and leukemia and a review of the literature”. Ann. Oncol., 2009, 20, 110.